Tumor infiltrating B cells and tertiary lymphoid structures are associated with tumor response to PD-L1 blockade in NSCLC

被引：0
|
作者：
Patil, Namrata S. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5518
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5518
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Role of PD-L1 and Tumor Mutational Burden in NSCLC Immunotherapy
    Peters, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S74 - S74
  • [42] Tumor Infiltrating Lymphocyte Expression of PD-1 Predicts Response to Anti-PD-1/PD-L1 Immunotherapy
    Bevins, Nicholas J.
    Okamura, Ryosuke
    Montesion, Meagan
    Adashek, Jacob J.
    Goodman, Aaron M.
    Kurzrock, Razelle
    JOURNAL OF IMMUNOTHERAPY AND PRECISION ONCOLOGY, 2022, 5 (04) : 90 - 97
  • [43] BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 Blockade
    Nikbakht, Neda
    Tiago, Manoela
    Erkes, Dan A.
    Chervoneva, Inna
    Aplin, Andrew E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (07) : 1612 - 1615
  • [44] Integrative analysis of NSCLC identifies tumor genetic profiles associated with PD-L1 expression
    Saigi, M.
    Pereira, C.
    Pros, E.
    Brambilla, E.
    Alburquerque, J.
    Baixeras, N.
    Sanchez-Cespedes, M.
    Nadal, E.
    ANNALS OF ONCOLOGY, 2017, 28
  • [45] Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells
    Xiaoqing Zhang
    Chen Cheng
    Jiyan Hou
    Xinyue Qi
    Xin Wang
    Ping Han
    Xuanming Yang
    Cellular & Molecular Immunology, 2019, 16 : 392 - 400
  • [46] Distinct contribution of PD-L1 suppression by spatial expression of PD-L1 on tumor and non-tumor cells
    Zhang, Xiaoqing
    Cheng, Chen
    Hou, Jiyan
    Qi, Xinyue
    Wang, Xin
    Han, Ping
    Yang, Xuanming
    CELLULAR & MOLECULAR IMMUNOLOGY, 2019, 16 (04) : 392 - 400
  • [47] To B or not to B in NSCLC: Functional characterisation of tumor infiltrating B cells in NSCLC
    Santiso, Ana
    Kindler, Oliver
    Zhu, Xiaodong
    Raftopoulou, Sofia
    Klymiuk, Ingeborg
    Maitz, Kathrin
    Mihalic, Zala
    Houghton, A. McGarry
    Kargl, Julia
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2024, 54 : 1590 - 1590
  • [48] Systemic and tumor associated IL-8 correlates with resistance to PD-L1 blockade
    Yuen, Kobe
    Liu, Lifen
    Li, Congfen
    Rishipathak, Deepali
    Williams, Patrick
    Kadel, Edward
    Koeppen, Hartmut
    Madireddi, Shravan
    Keerthivasan, Shilpa
    Chen, Ying-Jun
    Modrusen, Zora
    Banchereau, Romain
    Leng, Ning
    Hegde, Priti
    Huseni, Mahrukh
    Mariathasan, Sanjeev
    CANCER RESEARCH, 2020, 80 (16)
  • [49] Prognostic significance of PD-L1 expression on tumor cells and tumor-infiltrating mononuclear cells in upper tract urothelial carcinoma
    Bo Zhang
    Wei Yu
    Xueru Feng
    Zheng Zhao
    Yu Fan
    Yisen Meng
    Shuai Hu
    Yun Cui
    Qun He
    Hong Zhang
    Dong Li
    Zhisong He
    Liqun Zhou
    Jie Jin
    Wenke Han
    Medical Oncology, 2017, 34
  • [50] Synergy of nanodiamond-doxorubicin conjugates and PD-L1 blockade effectively turns tumor-associated macrophages against tumor cells
    Xu, Hua-Zhen
    Li, Tong-Fei
    Wang, Chao
    Ma, Yan
    Liu, Yan
    Zheng, Mei-Yan
    Liu, Zhang-Jun-Yan
    Chen, Jin-Bo
    Li, Ke
    Sun, Shi-Kuan
    Komatsu, Naoki
    Xu, Yong-Hong
    Zhao, Li
    Chen, Xiao
    JOURNAL OF NANOBIOTECHNOLOGY, 2021, 19 (01)
12345